Jul 01, 2014
Stemgent-Asterand (http://www.stemgent.com), an innovative provider of cellular reprogramming reagents and iPS cell reprogramming services, and tebu-bio (http://www.tebu-bio.com) are pleased to announce their new sales and marketing agreement...
Jan 30, 2014
tebu-bio is pleased to announce their agreement with EpiCypher™ to distribute their innovative product range throughout Europe
Jul 22, 2013
Researchers across Europe are now able to access StemCultures' FGF2 through tebu-bio’s pan-European network of offices.
Dec 18, 2012
tebu-bio announces today a distributor agreement with research antibody maker Biosensis bringing innovative tools for Life Sciences to European researchers
Jul 17, 2012
tebu-bio is pleased to announce their recent distribution agreement with CellResearch Corporation Pte Ltd.
Jul 13, 2012
tebu-bio is proud to announce that they have been awarded the designation of Certified Service Provider (CSP) of RayBiotech’s antibody array testing services.
Jul 03, 2012
tebu-bio is pleased to announce their recent partnership with Smartox Biotechnology
Apr 26, 2012
tebu-bio is pleased to announce their agreement with CH3 BioSystems to distribute their product range to the European market.
Mar 27, 2012
Bromodomains are a new emerging class of pharmaceutical targets in the field of Epigenetics. Bromodomains (BRDs) are protein domains involved in Epigenetics that recognize acetylated lysines.
Mar 26, 2012
Stimulated Emission Depletion Microscopy (or STED nanoscopy) offers a technological breakthrough in the environment of cell imaging by drastically increasing the resolution over traditional confocal microscopy.